[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_97":98},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","pystilhpwa1dqtxc5eszooexa","revision",2,"title","Aditxt, Inc. 终止与 Copley 的并购协议","originalTitle","Aditxt, Inc. (0001726711) (Filer)","summary","Aditxt, Inc. 与 Copley Acquisition Corp 于 10 月 9 日终止并购协议，协议自即日起失效。协议终止后，各方不再承担协议下的权利义务，仅部分条款继续有效。协议相关文件已提交 SEC。","reason","source",{"_11":87,"_88":89,"_90":91,"_92":57,"_93":94,"_95":96},"links",{"_84":85,"_63":86},"publishedAt","2026-10-15T20:05:27.000Z","discoveredAt","2026-10-15T20:16:08.572Z","timelineAt","category","tip","tags",[81,82,83],"stockSymbols",[80],"score",30,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","fo5tqj-jIvBs",{"_72":73,"_15":74},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","fbe6b397-1e26-4efd-bd8b-c696863f149b","Aditxt 与 Copley 并购协议终止",{"_72":73,"_15":74},"zh","

UNITED\nSTATES

SECURITIES\nAND EXCHANGE COMMISSION

Washington,\nD.C. 20549

FORM 8-K

CURRENT\nREPORT

Pursuant\nto Section 13 or 15(d) of the Securities Exchange Act of 1934

Date\nof Report (Date of earliest event reported): October\n9, 2026

ADITXT,\nINC.

(Exact\nname of registrant as specified in its charter)

Delaware

(State\nor other jurisdiction of incorporation)

\n \n \n \n \n \n \n \n \n

001-39336		82-3204328
(Commission\n File Number)		(I.R.S.\n Employer \n Identification No.)

2569 Wyandotte Street, Suite 101

Mountain View, California\n94043

(Address\nof principal executive offices, including zip code)

(650) 870-1200

(Registrant’s\ntelephone number, including area code)

N/A

(Former\nname or former address, if changed since last report)

Check\nthe appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under\nany of the following provisions:

\n \n \n \n

☐	Written\n communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

\n \n \n \n

☐	Soliciting\n material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

\n \n \n \n

☐	Pre-commencement\n communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

\n \n \n \n

☐	Pre-commencement\n communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities\nregistered pursuant to Section 12(b) of the Act:

\n \n \n \n \n \n \n \n \n \n \n \n \n

Title\n of each class		Trading\n Symbol(s)		Name\n of each exchange on which registered
Common Stock, par value $0.001 per share		ADTX		The\n Nasdaq Stock\n Market LLC

Indicate\nby check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)\nor Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging\ngrowth company ☐

If\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item\n1.01. Entry into a Material Definitive Agreement.

The\ninformation set forth in Item 1.02 below is hereby incorporated by reference into this Item 1.01.

Item\n1.02. Termination of a Material Definitive Agreement.

As\npreviously disclosed, on June 10, 2026, Ignite Proteomics, LLC, a Delaware limited liability company (“Ignite”)\nand a wholly-owned subsidiary of Aditxt, Inc. (the “Company”), entered into a Business Combination Agreement\n(the “Business Combination Agreement”) with Copley Acquisition Corp, a Cayman Islands exempted company (“Copley”),\nIgnite Proteomics Holdings, Inc., a Delaware corporation (“Pubco”), Ignite Merger Sub I Inc., a Delaware corporation\nand a wholly-owned subsidiary of Pubco (“SPAC Merger Sub”), Ignite Merger Sub II LLC, a Delaware limited liability\ncompany and a wholly-owned subsidiary of Pubco (“Company Merger Sub”), Jeffrey M. Busch, solely in his capacity\nas the Seller Representative, and Chibo Tang, solely in his capacity as the SPAC Representative.

Termination\nof Business Combination Agreement

On\nOctober 9, 2026, the parties to the Business Combination Agreement entered into a Mutual Termination Agreement (the “Termination\nAgreement”), pursuant to which Copley and Ignite mutually agreed to terminate the Business Combination Agreement pursuant\nto Section 8.1(a) thereof, effective immediately.

As\na result of the Termination Agreement, no party has any further rights, remedies, liabilities or obligations under the Business Combination\nAgreement, except that Sections 6.14, 6.15, 8.2 and 9.1 and Article X thereof survive. Each Ancillary Document (as defined in the Business\nCombination Agreement), including the Seller Support Agreements, the Insider Letter Amendment and the Lock-Up Agreements, automatically\nterminated concurrently with the Business Combination Agreement. The Termination Agreement also provides that each party will bear its\nown expenses and contains mutual releases of claims relating to the Business Combination Agreement and the transactions contemplated\nthereby, other than claims under the Termination Agreement.

The\nforegoing description of the Business Combination Agreement and the Termination Agreement does not purport to be complete and is qualified\nin its entirety by reference to the full text of the Business Combination Agreement, previously filed as Exhibit 2.1 to the Company’s\nCurrent Report on Form 8-K filed with the Securities and Exchange Commission on June 10, 2026, and the Termination Agreement, filed as\nExhibit 10.1 to this Current Report on Form 8-K, each of which is incorporated herein by reference.

Forward-Looking\nStatements

This\nCurrent Report on Form 8-K contains forward-looking statements within the meaning of applicable federal securities laws. These forward-looking\nstatements include statements regarding the potential effects of the termination of the Business Combination Agreement on the Company\nand its business, operations, financial condition and future plans. Forward-looking statements are based on current expectations and\nare subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements,\nincluding the potential financial, operational and other consequences of the termination of the Business Combination Agreement; costs\nand expenses incurred in connection with the terminated transaction; the Company’s ability to pursue alternative strategic transactions\nor business opportunities; the Company’s ability to obtain additional financing and maintain sufficient liquidity to fund its operations;\nand the other risks described under “Risk Factors” in the Company’s Annual Report on Form 10-K and subsequent Quarterly\nReports on Form 10-Q filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking\nstatements, which speak only as of the date hereof. The Company undertakes no obligation to update any forward-looking statement, except\nas required by law.

Item\n9.01. Financial Statements and Exhibits.

(d)\nExhibits

\n \n \n \n \n \n \n \n \n \n \n \n \n

Exhibit\n No.		Description
10.1		Termination\n Agreement, dated as of October 9, 2026, by and among Copley Acquisition Corp, Ignite Proteomics, LLC, Ignite Proteomics Holdings,\n Inc., Ignite Merger Sub I Inc., Ignite Merger Sub II LLC, and the other parties thereto.
104		Cover Page Interactive Data File (embedded\n within the Inline XBRL document)

SIGNATURES

Pursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

ADITXT, INC.

Date: October 15, 2026

By:	/s/ Jeffrey M. Busch
Name:	Jeffrey M. Busch
Title:	Interim Chief Executive Officer

","zhKind","complete","ADTX","政策与监管","退市","停复牌","aihot","/items/pystilhpwa1dqtxc5eszooexa","https://www.sec.gov/Archives/edgar/data/1726711/000121390026109826/0001213900-26-109826-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1792454400&sig=3dbe6cd67490ee5b","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1792454400&sig=28d09d2ec91c5a63 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1792454400&sig=4324ec5a457d0f39 96w","changelogVersion","2026-10-01T08:00"]